Surface Plasmon Resonance Market Report 2026

The surface plasmon resonance market size has grown rapidly in recent years. It will grow from $1.33 billion in 2025 to $1.49 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to expansion of pharmaceutical and biotech research activities, increased use of biomolecular interaction studies, growth in academic life science research, rising demand for analytical precision tools, availability of advanced optical sensing technologies.

The surface plasmon resonance market size is expected to see rapid growth in the next few years. It will grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing investment in biologics and biosimilars development, rising demand for high-throughput screening tools, expansion of personalized medicine research, growing adoption of biosensors in diagnostics, increasing focus on real-time molecular analytics. Major trends in the forecast period include increasing adoption of high-sensitivity spr imaging systems, rising demand for label-free biomolecular analysis, growing integration of spr in drug discovery pipelines, expansion of portable and multi-channel spr sensors, enhanced focus on real-time interaction analysis.

The growing adoption of personalized medicine is expected to drive the expansion of the surface plasmon resonance market in the coming years. Personalized medicine is a healthcare approach that tailors treatment and prevention strategies based on an individual’s genetic makeup, environmental factors, and lifestyle. The rise of personalized medicine is fueled by advances in genomics, the development of targeted therapies, and the increasing demand for precise and effective treatments. Surface plasmon resonance supports personalized medicine by enabling real-time analysis of biomolecular interactions, identifying specific biomarkers, and optimizing drug therapies for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based healthcare organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six approvals in 2022. The 2023 approvals also included seven cancer drugs and three for other diseases and conditions. Thus, the increasing adoption of personalized medicine is driving growth in the surface plasmon resonance market.

Leading companies in the surface plasmon resonance market are increasingly focusing on developing advanced biomolecular analysis technologies, such as high-throughput SPR biosensor platforms, to maintain a competitive edge. SPR leverages an optical phenomenon at metal-dielectric interfaces to detect binding events in real time without the need for labels. For instance, in February 2023, Carterra, a US-based biotechnology instrumentation company, launched its high-throughput SPR platform, the LSA^XT, which offers enhanced sensitivity, significantly higher sample throughput, and reduced sample consumption, enabling efficient screening of membrane proteins, small molecules, and kinetic interactions. These high-throughput, sensitive SPR systems allow pharmaceutical and biotech companies to accelerate drug discovery and biologics characterization. However, this trend also places greater demands on instrument vendors to ensure reproducibility and manage larger volumes of data.

In October 2024, Bruker Corporation, a US-based manufacturer of scientific instruments for molecular and materials research, acquired Dynamic Biosensors GmbH (DBS) for an undisclosed sum. This acquisition enables Bruker to expand its biophysical instrumentation portfolio by integrating its existing high-throughput SPR systems with DBS’s innovative biosensor technologies, enhancing capabilities in molecular interaction and kinetics analysis. Dynamic Biosensors, a Germany-based developer of advanced biosensor platforms - particularly the helix biosensor series - supports detailed studies of molecular and cellular interactions, aiding both drug discovery and basic or medical research.

Major companies operating in the surface plasmon resonance market are GE HealthCare Technologies Inc., Sartorius AG, Cytiva, Bio-Rad Laboratories Inc., Bruker Corporation, HORIBA Ltd., Quanterix Corporation, Jubilant Biosys Limited, Quantum Design Inc., Reichert Inc., NanoSPR Devices, Creative BioMart Inc., Biocompare, Carterra Inc., NICOYA AB, Biosensing Instrument Inc., Plexera LLC, Insplorion AB, BioNavis Ltd., Affinité Instruments, IBIS Technologies B.V.

North America was the largest region in the surface plasmon resonance market in 2025. The regions covered in the surface plasmon resonance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surface plasmon resonance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the surface plasmon resonance market by increasing costs of imported optical components, precision sensors, imaging modules, and analytical reagents required for SPR systems. Research institutions and biopharmaceutical companies in North America and Europe are most affected due to dependence on specialized imported instrumentation, while Asia-Pacific faces higher system acquisition costs. These tariffs are elevating equipment procurement budgets and extending replacement cycles. However, they are also promoting regional manufacturing of optical components, local reagent production, and increased collaboration between domestic research and instrument suppliers.

The surface plasmon resonance market research report is one of a series of new reports that provides surface plasmon resonance market statistics, including surface plasmon resonance industry global market size, regional shares, competitors with a surface plasmon resonance market share, detailed surface plasmon resonance market segments, market trends and opportunities, and any further data you may need to thrive in the surface plasmon resonance industry. This surface plasmon resonance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Surface plasmon resonance (SPR) is an optical method used to monitor molecular interactions by detecting changes in the refractive index on a sensor surface. It enables real-time, label-free analysis of biomolecular interactions, including protein-protein, protein-DNA, and antibody-antigen binding events.

The primary product categories in SPR include imaging systems, sensor systems, and reagents. Imaging systems allow real-time visualization and analysis of biomolecular interactions. SPR technologies include prism-based SPR, grating-based SPR, and other variants. These systems have diverse applications such as drug discovery, drug formulation, controlled drug release, drug-cell interaction studies, material science, and biosensing. Key end-users include academic and research institutions, the food and beverage industry, biopharmaceutical companies, contract research organizations (CROs), and others.

The surface plasmon resonance market consists of revenues earned by entities by providing services such as biosensor development services, assay development services, contract research services, data analysis services, and instrument maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The surface plasmon resonance market also includes sales of benchtop and portable SPR systems, metallic sensor chips, functionalized sensor chips, buffers, and solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.